Our proprietary AI drug discovery platform compresses years of traditional research into months. Leveraging quantum-inspired algorithms, molecular simulation, and predictive toxicology, we're redefining the path to bedside.
From target identification to lead optimization, our closed-loop AI system eliminates guesswork and accelerates validated candidates into clinical development.
Our multimodal AI analyzes genomic, proteomic, and clinical datasets to pinpoint high-probability disease targets, filtering out low-efficacy pathways before wet-lab validation.
Generative chemistry models design novel, synthetically accessible molecules with optimized potency, selectivity, and pharmacokinetic profiles in silico.
Deep learning networks predict absorption, distribution, metabolism, excretion, and toxicity (ADMET), drastically reducing late-stage attrition and regulatory risk.
Enterprise-ready infrastructure designed to meet regulatory standards while pushing the boundaries of computational biology.
Hybrid quantum-classical algorithms solve complex molecular conformation problems exponentially faster than classical HPC systems.
Train models across partner pharmaceutical datasets without moving sensitive IP, ensuring compliance with HIPAA, GDPR, and FDA data standards.
GPU-accelerated physics engines simulate protein-ligand interactions at atomic resolution, providing structural insights indistinguishable from crystallography.
Automated generation of IND-enabling documentation, audit trails, and validation metrics aligned with ICH and FDA AI/ML guidance frameworks.
Current therapeutic candidates advancing through our AI-accelerated discovery engine.
Partner with Zenth Health Sciences to integrate our AI drug discovery platform into your R&D workflow. Licensed to biotech, pharma, and academic research institutions.